Interleukin-1 Receptor-Associated Kinase 3 (IRAK3) Peptide
IRAK3
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN978589
Quick Overview for Interleukin-1 Receptor-Associated Kinase 3 (IRAK3) Peptide (ABIN978589)
Target
IRAK3
(Interleukin-1 Receptor-Associated Kinase 3 (IRAK3))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-IRAK3 antibody (Catalog #: ARP40709_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- IRAK3 (Interleukin-1 Receptor-Associated Kinase 3 (IRAK3))
-
Background
-
IRAK3 contains 1 protein kinase domain and 1 death domain and belongs to the Ser/Thr protein kinase family, Pelle subfamily. It inhibits dissociation of IRAK1 and IRAK4 from the Toll-like receptor signaling complex by either inhibiting the phosphorylation of IRAK1 and IRAK4 or stabilizing the receptor complex.
Alias Symbols: ASRT5, IRAKM
Protein Interaction Partner: IRAK1,IRAK2,IRAK3,MYD88,TICAM2,TRAF6,IRAK1,IRAK2,IRAK3,MYD88,TICAM2,TRAF6,MYD88,TRAF6
Protein Size: 596 -
Molecular Weight
- 66 kDa
-
Gene ID
- 11213
-
NCBI Accession
- NM_007199, NP_009130
-
UniProt
- Q9Y616
Target
-
You are here:
